News Conference News ACC 2019 REDUCE-IT Subanalysis: Icosapent Ethyl Reduces Total and Recurrent CV Events Yael L. Maxwell March 22, 2019
News Conference News Flu Vaccination Tied to Less MI in Hospitalized Patients Todd Neale March 13, 2019
News Daily News ISCHEMIA Patients: High Rates of Severe-to-Moderate Ischemia, Multivessel CAD Michael O'Riordan March 01, 2019
News Daily News Rising Number of CV-Related Maternal Deaths Spurs Need for #CardioObstetrics Caitlin E. Cox February 27, 2019
News Daily News Age Shouldn’t Be a Barrier to Statin Therapy, Meta-analysis Suggests Michael O'Riordan February 08, 2019
News Features Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis? Michael O'Riordan February 01, 2019
News Daily News Most Cardiovascular Drugs Can Be Safely Used in Pregnancy, Review Suggests Todd Neale February 01, 2019
News Daily News European Regulators Strike Secondary Prevention Claim for Omega-3 Drugs Shelley Wood December 18, 2018
News Daily News Benefits of Statins Only Exceed Harms at Higher 10-Year Risk Thresholds, Study Suggests Michael O'Riordan December 03, 2018
News Daily News Angina Without Obstructive Stenosis: No Longer a ‘Black Box’ Mystery, Say Experts Michael O'Riordan November 23, 2018
News Conference News AHA 2018 EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits Michael O'Riordan November 16, 2018
News Conference News AHA 2018 Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study Michael O'Riordan November 15, 2018
News Conference News VIVA 2018 Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease L.A. McKeown November 15, 2018
News Conference News AHA 2018 Canakinumab Reduces Heart-Failure Hospitalizations Among Responders: CANTOS Subanalysis Caitlin E. Cox November 13, 2018
News Conference News AHA 2018 Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT Michael O'Riordan November 10, 2018
News Conference News AHA 2018 REDUCE-IT: Prescription Fish Oil Prevents CV Events in Patients With High Triglycerides Todd Neale November 10, 2018
News Conference News AHA 2018 VITAL: No Benefits to Vitamin D and Omega-3s in Reducing Major CV Events, Cancer Shelley Wood November 10, 2018